Drug Profile
Research programme: immuno-oncology therapeutics - Batu Biologics
Alternative Names: Cancer vaccine - Batu Biologics; DendroVax™; hp91; Immittam™; ImmStem™; ImmXcyte™; Stem cell therapy - Batu Biologics; ValloVax™Latest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator Batu Biologics
- Class Cancer vaccines; Dendritic cell vaccines; Gene therapies; Stem cell therapies
- Mechanism of Action Angiogenesis inhibitors; Cell replacements; Immunomodulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glioblastoma; Non-small cell lung cancer; Solid tumours
- Discontinued Septic shock
Most Recent Events
- 28 Oct 2021 No recent reports of development identified for preclinical development in Glioblastoma in USA (Parenteral)
- 28 Oct 2021 No recent reports of development identified for preclinical development in Non-small-cell-lung-cancer in USA (Parenteral)
- 28 Oct 2021 No recent reports of development identified for preclinical development in Solid-tumours in USA (Parenteral)